Abstract:As a critical effector molecule of the human innate immune system, the antimicrobial peptide LL-37 possesses broad-spectrum antimicrobial activity, immunomodulatory effects, and dual pro-inflammatory and anti-inflammatory functions. Recent studies have revealed that LL-37 plays a complex role in the initiation and progression of atherosclerosis (As). It affects the plaque microenvironment through its antimicrobial effects, regulates inflammatory responses, oxidative stress, and the behaviors of vascular smooth muscle cells (VSMC), and participates in the modulation of plaque formation and stability. This article systematically reviews the biological characteristics and functional mechanisms of LL-37, its role in As, and the LL-37-mtDNA complex formed by LL-37 and mtDNA, aiming to provide a theoretical basis for therapeutic strategies targeting the LL-37-mtDNA complex.